BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
T cell differentiation
,
Breast Cancer
,
Hypothalamus
,
DNA fingerprint
,
Aspirin
,
GATA1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
G protein pathway suppressor 2
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Testes
Bladder
Trigeminal ganglia
Pancreas
Pons
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Irritable bowel syndrome
Muscle atrophy
Mood disorder
Aging
Eating / feeding / drinking finding
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
carbetapentane
Mesalamine
SU 5402
Josamycin
harpagoside
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
HCFC2
P2RY14
DLX1
CREB1
PVT1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Buffering and proteolysis are induced upon segmental haploidy in D. melanogaster
Broad Connectivity Map (CMAP 2.0) compound database
Breast cancer MCF7 cell polysomal, subpolysomal RNAs following eIF4A1 knockdown
Bone marrow from AML-M1 patients with or without GATA2 overexpression and FLT3 mutation
Expression profiles in testis exposed to endocrine disruptors
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for G protein pathway suppressor 2
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Paclitaxel Protein Bound Plus Cisplatin Plus Gemcitabine and Paricalcitol for Pancreatic Adenocarcin…
Treatment With Azacitidine of Recurrent Gliomas With IDH1/2 Mutation
A Phase II Single-arm Intervention Trial of Nelfinavir in Patients With Grade 2/3 or 3 Cervical Intr…
Immunohistochemical Evaluation of Protein P16 Expression in Ovarian Germ Cell Tumors.
A Phase 2 Study to Evaluate the Triplet Combination of Pemetrexed Plus AB928 (Etrumadenant) + AB122 …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ